---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-000010"
form_type: "8-K/A"
ticker: "HBIO"
cik: "0001123494"
company_name: "HARVARD BIOSCIENCE INC"
filed_at: "2023-01-03T23:59:59+00:00"
generated_at: "2026-06-20T20:44:00.131128+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Harvard Bioscience sets compensation for Interim CFO Cote: $270K salary, bonus, $75K RSU

## Summary
- Annual base salary of $270,000 as Interim CFO and Treasurer, effective January 1, 2023.
- Eligible for cash bonus of 25% of 2023 base salary, paid in quarterly installments.
- One-time equity award of RSUs with $75,000 grant date value, vesting December 29, 2023.
- Compensation package is in addition to prior VP Finance terms from April 2022 offer letter.

## SEC filing metadata
- accession: 0001171843-23-000010
- form_type: 8-K/A
- ticker: HBIO
- cik: 0001123494
- company_name: HARVARD BIOSCIENCE INC
- filed_at: 2023-01-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1123494/000117184323000010/0001171843-23-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1123494/000117184323000010/f8ka_010323.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-000010
- JSON: https://secwatch.observer/filing/0001171843-23-000010.json
- Plain text: https://secwatch.observer/filing/0001171843-23-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.